(+)-Dehydroabietylamine derivatives target triple-negative breast cancer

Taotao Ling(Louisiana State University), Fatima Rivas(Louisiana State University Health Sciences Center New Orleans), Gustavo A. Miranda‐Carboni(University of Tennessee Health Science Center), Lekh Nath S. Gautam(St. Jude Children's Research Hospital), My Tran(St. Jude Children's Research Hospital), Iram Fatima(Jamia Hamdard), Michele Connelly(St. Jude Children's Research Hospital), Miguel A. González(Universitat de València), Rachael K. Wood
European Journal of Medicinal Chemistry
July 23, 2015
Cited by 35


Related Papers